United States Pharmaceuticals

Aquestive Therapeutics Inc (AQST)

Track

Over the last 90 days, Aquestive Therapeutics Inc. has seen significant insider selling, with a net value of -$139,423. Notable transactions include sales by President and CEO Daniel Barber and Director Julie Krop. The company's stock has experienced a 5.6% increase in the last 90 days, trading near its 52-week low.
Ticker: AQST Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aquestive Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Daniel Barber
Officer
1 sale — total 100,000 USD
Proposed sale 15 Jul 2026
Value US$2,255,278.80 | Price 393.09 | Shares 20,540
Planned sale 23 Jun 2026
Value US$891,983.24 | Price 237.00 | Shares 85,198
Proposed sale 23 Jun 2026
Value US$118,000.00 | Price 4.72 | Shares 25,000
Sale 15 Jun 2026
Value US$104,010.00 | Price 4.16 | Shares 25,000
Proposed sale 15 Jun 2026
Value US$104,250.00 | Price 4.17 | Shares 25,000
Sale 15 May 2026
Value US$35,413.45 | Price 4.29 | Shares 8,257
Proposed sale 15 May 2026
Value US$39,055.61 | Price 4.73 | Shares 8,257
Sale 10 Mar 2026
Value US$167,345.65 | Price 4.17 | Shares 40,102
Sale 10 Mar 2026
Value US$124,413.82 | Price 4.17 | Shares 29,814
Sale 10 Mar 2026
Value US$753,965.12 | Price 4.17 | Shares 180,677
Sale 10 Mar 2026
Value US$105,622.80 | Price 4.17 | Shares 25,311
Sale 10 Mar 2026
Value US$65,687.19 | Price 4.17 | Shares 15,741
Sale 10 Mar 2026
Value US$191,085.84 | Price 4.17 | Shares 45,791
Sale 10 Mar 2026
Value US$243,093.94 | Price 4.17 | Shares 58,254
Proposed sale 17 Nov 2025
Value US$286,209.00 | Price 5.39 | Shares 53,100
Planned sale 15 Oct 2025
Value US$141,904.00 | Price 7.00 | Shares 20,272
Planned sale 15 Oct 2025
Value US$473,700.75 | Price 7.01 | Shares 67,575
Planned sale 15 Oct 2025
Value US$70,000.00 | Price 7.00 | Shares 10,000
Proposed sale 15 Oct 2025
Value US$278,943.00 | Price 6.88 | Shares 40,544
Proposed sale 15 Oct 2025
Value US$464,916.00 | Price 6.88 | Shares 67,575
Proposed sale 15 Oct 2025
Value US$70,000.00 | Price 7.00 | Shares 10,000
Proposed sale 26 Sep 2025
Value US$63,000.00 | Price 6.30 | Shares 10,000
Planned sale 26 Sep 2025
Value US$63,000.00 | Price 6.30 | Shares 10,000
Planned sale 26 Sep 2025
Value US$551,191.06 | Price 6.03 | Shares 91,343
Proposed sale 26 Sep 2025
Value US$480,464.18 | Price 5.26 | Shares 91,343
Planned sale 19 Sep 2025
Value US$2,400.00 | Price 6.00 | Shares 400
Proposed sale 19 Sep 2025
Value US$1,976.00 | Price 4.94 | Shares 400
Planned sale 5 Sep 2025
Value US$79,500.00 | Price 5.30 | Shares 15,000
Proposed sale 5 Sep 2025
Value US$79,500.00 | Price 5.30 | Shares 15,000
Planned sale 4 Sep 2025
Value US$310,900.00 | Price 5.00 | Shares 62,180
Proposed sale 4 Sep 2025
Value US$245,611.00 | Price 3.95 | Shares 62,180
Sale 26 Nov 2024
Value US$214.06 | Price 4.87 | Shares 44
Planned sale 15 Mar 2024
Value US$300,000.00 | Price 6.00 | Shares 50,000
Proposed sale 15 Mar 2024
Value US$300,000.00 | Price 6.00 | Shares 50,000
Planned sale 8 Mar 2024
Value US$129,685.00 | Price 5.19 | Shares 25,000
Proposed sale 8 Mar 2024
Value US$140,000.00 | Price 5.60 | Shares 25,000
Buy 14 Jun 2022
Value US$4,050.00 | Price 0.81 | Shares 5,000
Buy 8 Jun 2022
Value US$2,201.28 | Price 0.96 | Shares 2,293
Buy 8 Jun 2022
Value US$13,210.56 | Price 0.96 | Shares 13,761
Buy 8 Jun 2022
Value US$44,036.16 | Price 0.96 | Shares 45,871
Buy 8 Jun 2022
Value US$88,073.28 | Price 0.96 | Shares 91,743
Planned sale 10 Feb 2021
Value US$158,355.00 | Price 6.75 | Shares 23,460
Planned sale 9 Feb 2021
Value US$77,895.00 | Price 6.75 | Shares 11,540
Planned sale 8 Feb 2021
Value US$265,148.00 | Price 6.50 | Shares 40,792
Planned sale 18 Aug 2020
Value US$24,000.00 | Price 8.00 | Shares 3,000
Planned sale 4 Jun 2020
Value US$255,310.00 | Price 5.11 | Shares 50,000
Planned sale 8 May 2020
Value US$200,000.00 | Price 5.00 | Shares 40,000
Planned sale 29 Apr 2020
Value US$180,000.00 | Price 4.50 | Shares 40,000
Planned sale 27 Apr 2020
Value US$160,000.00 | Price 4.00 | Shares 40,000
Planned sale 14 Apr 2020
Value US$148,000.00 | Price 3.70 | Shares 40,000
Buy 16 Mar 2020
Value US$3,000.00 | Price 1.50 | Shares 2,000
Buy 16 Mar 2020
Value US$21,624.40 | Price 1.54 | Shares 14,000
Buy 27 Aug 2019
Value US$7,980.00 | Price 3.99 | Shares 2,000
Buy 21 Aug 2019
Value US$3,429.00 | Price 3.81 | Shares 900
Buy 20 Aug 2019
Value US$43,000.62 | Price 3.80 | Shares 11,310
Buy 19 Aug 2019
Value US$40,547.45 | Price 3.77 | Shares 10,761
Buy 14 Aug 2019
Value US$3,650.00 | Price 3.65 | Shares 1,000
Buy 14 Aug 2019
Value US$3,697.00 | Price 3.70 | Shares 1,000
Buy 13 Aug 2019
Value US$4,045.00 | Price 4.05 | Shares 1,000
Buy 12 Aug 2019
Value US$2,286.00 | Price 3.81 | Shares 600
Buy 9 Aug 2019
Value US$7,990.00 | Price 4.00 | Shares 2,000
Buy 9 Aug 2019
Value US$3,925.00 | Price 3.93 | Shares 1,000
Buy 9 Aug 2019
Value US$7,680.00 | Price 3.84 | Shares 2,000
Buy 9 Aug 2019
Value US$40,747.00 | Price 4.07 | Shares 10,000
Buy 9 Aug 2019
Value US$3,990.00 | Price 3.99 | Shares 1,000
Buy 10 Dec 2018
Value US$7,780.00 | Price 7.78 | Shares 1,000
Buy 10 Dec 2018
Value US$8,000.00 | Price 8.00 | Shares 1,000
Buy 6 Dec 2018
Value US$17,380.00 | Price 8.69 | Shares 2,000
Buy 6 Dec 2018
Value US$44,350.00 | Price 8.87 | Shares 5,000
Buy 27 Nov 2018
Value US$10,570.00 | Price 10.57 | Shares 1,000
Buy 27 Nov 2018
Value US$9,870.00 | Price 9.87 | Shares 1,000
Buy 26 Nov 2018
Value US$5,170.00 | Price 10.34 | Shares 500
Buy 23 Nov 2018
Value US$19,305.00 | Price 9.90 | Shares 1,950
Buy 21 Nov 2018
Value US$14,666.75 | Price 10.15 | Shares 1,445
Buy 21 Nov 2018
Value US$61,020.00 | Price 10.17 | Shares 6,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-15 PrS Proposed sale
3.0
Daniel Barber

Officer

Officer
20,540
393.09
US$2,255,279 		20,540 393.09 US$2,255,279
2026-06-24 2026-06-23 PlS Planned sale
Krop Julie
Non-Executive Director
85,198 -1.5%
237.00
US$891,983 		85,198 -1.5% 237.00 US$891,983
2026-06-23 2026-06-23 PrS Proposed sale
JULIE KROP

Director

Non-Executive Director
5,396
124.21
US$2,451,360 		5,396 124.21 US$2,451,360
2026-06-16 2026-06-15 S Sale
3.0
Barber Daniel

President and CEO

Officer
25,000 -3.8%
4.16
US$104,010 		25,000 -3.8% 4.16 US$104,010
2026-06-15 2026-06-15 PrS Proposed sale
3.0
Daniel Barber

Officer

Officer
25,000
4.17
US$104,250 		25,000 4.17 US$104,250
2026-05-18 2026-05-15 S Sale
3.0
Barber Daniel

President and CEO

Officer
8,257 -1.2%
4.29
US$35,413 		8,257 -1.2% 4.29 US$35,413
2026-05-15 2026-05-15 PrS Proposed sale
3.0
Daniel Barber

Officer

Officer
8,257
4.73
US$39,056 		8,257 4.73 US$39,056
2026-03-11 2026-03-10 S Sale
3.4
BRAENDER LORI J

Chief Legal Officer

Officer
40,102 -8.3%
4.17
US$167,346 		40,102 -8.3% 4.17 US$167,346
2026-03-11 2026-03-10 S Sale
3.2
Boyd Peter E.

Chief People Officer

Officer
29,814 -8.1%
4.17
US$124,414 		29,814 -8.1% 4.17 US$124,414
2026-03-11 2026-03-10 S Sale
3.0
Barber Daniel

President and CEO

Officer
180,677 -15.2%
4.17
US$753,965 		180,677 -15.2% 4.17 US$753,965
2026-03-11 2026-03-10 S Sale
2.1
Cioffi Melina

SVP, Regulatory Affairs

Officer
25,311 -8.4%
4.17
US$105,623 		25,311 -8.4% 4.17 US$105,623
2026-03-11 2026-03-10 S Sale
2.1
Korczynski Sherry

Chief Commercial Officer

Officer
15,741 -6.1%
4.17
US$65,687 		15,741 -6.1% 4.17 US$65,687
2026-03-11 2026-03-10 S Sale
2.7
Jung Cassie

Chief Operating Officer

Officer
45,791 -14.3%
4.17
US$191,086 		45,791 -14.3% 4.17 US$191,086
2026-03-11 2026-03-10 S Sale
2.1
TOTH A ERNEST JR

Chief Financial Officer

Officer
58,254 -13.4%
4.17
US$243,094 		58,254 -13.4% 4.17 US$243,094
2025-11-17 2025-11-17 PrS Proposed sale
Carl N. Kraus

Affiliate
53,100
5.39
US$286,209 		53,100 5.39 US$286,209
2025-10-17 2025-10-15 PlS Planned sale
Kraus Carl N

Chief Medical Officer

Officer
20,272 -6.7%
7.00
US$141,904 		20,272 -6.7% 7.00 US$141,904
2025-10-17 2025-10-15 PlS Planned sale
2.7
Jung Cassie

Chief Operating Officer

Officer
67,575 -21.9%
7.01
US$473,701 		67,575 -21.9% 7.01 US$473,701
2025-10-17 2025-10-15 PlS Planned sale
3.2
Boyd Peter E.

See Remarks

Officer
10,000 -3.6%
7.00
US$70,000 		10,000 -3.6% 7.00 US$70,000
2025-10-15 2025-10-15 PrS Proposed sale
Carl N. Kraus

Officer

Officer
40,544
6.88
US$278,943 		40,544 6.88 US$278,943
2025-10-15 2025-10-15 PrS Proposed sale
2.7
CASSIE JUNG

Officer

Officer
67,575
6.88
US$464,916 		67,575 6.88 US$464,916
2025-10-15 2025-10-15 PrS Proposed sale
3.2
Peter Boyd

Officer

Officer
10,000
7.00
US$70,000 		10,000 7.00 US$70,000
2025-09-29 2025-09-26 PrS Proposed sale
3.2
Peter Boyd

Officer

Officer
10,000
6.30
US$63,000 		10,000 6.30 US$63,000
2025-09-29 2025-09-26 PlS Planned sale
3.2
Boyd Peter E.

See Remarks

Officer
10,000 -3.5%
6.30
US$63,000 		10,000 -3.5% 6.30 US$63,000
2025-09-29 2025-09-26 PlS Planned sale
3.0
Barber Daniel

President and CEO

Executive Director
91,343 -9.0%
6.03
US$551,191 		91,343 -9.0% 6.03 US$551,191
2025-09-26 2025-09-26 PrS Proposed sale
3.0
DANIEL BARBER

Director; Officer

Executive Director
91,343
5.26
US$480,464 		91,343 5.26 US$480,464
2025-09-22 2025-09-19 PlS Planned sale
3.0
Barber Daniel

President and CEO

Executive Director
400 -0.0%
6.00
US$2,400 		400 -0.0% 6.00 US$2,400
2025-09-19 2025-09-19 PrS Proposed sale
3.0
DANIEL R BARBER

Officer

Officer
400
4.94
US$1,976 		400 4.94 US$1,976
2025-09-08 2025-09-05 PlS Planned sale
3.2
Boyd Peter E.

See Remarks

Officer
15,000 -4.9%
5.30
US$79,500 		15,000 -4.9% 5.30 US$79,500
2025-09-05 2025-09-05 PrS Proposed sale
3.2
Boyd Peter E.

Officer

Officer
15,000
5.30
US$79,500 		15,000 5.30 US$79,500
2025-09-08 2025-09-04 PlS Planned sale
2.7
Jung Cassie

Chief Operating Officer

Officer
62,180 -18.0%
5.00
US$310,900 		62,180 -18.0% 5.00 US$310,900
2025-09-04 2025-09-04 PrS Proposed sale
2.7
CASSIE JUNG

Officer

Officer
62,180
3.95
US$245,611 		62,180 3.95 US$245,611
2024-11-27 2024-11-26 S Sale
2.7
Jung Cassie

Chief Operating Officer

Officer
44 -100.0%
4.87
US$214 		44 -100.0% 4.87 US$214
2024-03-19 2024-03-15 PlS Planned sale
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer

Officer
50,000 -4.8%
6.00
US$300,000 		50,000 -4.8% 6.00 US$300,000
2024-03-15 2024-03-15 PrS Proposed sale
2.2
Schobel Alexander Mark

Officer

Officer
50,000
6.00
US$300,000 		50,000 6.00 US$300,000
2024-03-12 2024-03-08 PlS Planned sale
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer

Officer
25,000 -2.3%
5.19
US$129,685 		25,000 -2.3% 5.19 US$129,685
2024-03-08 2024-03-08 PrS Proposed sale
2.2
Schobel Alexander Mark

Officer

Officer
25,000
5.60
US$140,000 		25,000 5.60 US$140,000
2022-06-15 2022-06-14 B Purchase
3.2
Boyd Peter E.

SVP-Bus. Process & Info. Tech.

Officer
5,000 +9.2%
0.81
US$4,050 		5,000 +9.2% 0.81 US$4,050
2022-06-10 2022-06-08 B Purchase
3.2
Boyd Peter E.

SVP-Bus. Process & Info. Tech.

Officer
2,293 +4.4%
0.96
US$2,201 		2,293 +4.4% 0.96 US$2,201
2022-06-10 2022-06-08 B Purchase
3.4
BRAENDER LORI J

General Counsel

Officer
13,761 +55.0%
0.96
US$13,211 		13,761 +55.0% 0.96 US$13,211
2022-06-10 2022-06-08 B Purchase
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer

Officer
45,871 +5.5%
0.96
US$44,036 		45,871 +5.5% 0.96 US$44,036
2022-06-10 2022-06-08 B Purchase
3.0
Barber Daniel

Chief Executive Officer

Officer
91,743 +90.0%
0.96
US$88,073 		91,743 +90.0% 0.96 US$88,073
2021-02-10 2021-02-10 PlS Planned sale
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer

Officer
23,460 -2.7%
6.75
US$158,355 		23,460 -2.7% 6.75 US$158,355
2021-02-10 2021-02-09 PlS Planned sale
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer

Officer
11,540 -1.3%
6.75
US$77,895 		11,540 -1.3% 6.75 US$77,895
2021-02-09 2021-02-08 PlS Planned sale
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer

Officer
40,792 -4.5%
6.50
US$265,148 		40,792 -4.5% 6.50 US$265,148
2020-08-19 2020-08-18 PlS Planned sale
Maxwell John T.

SVP-Chief Financial Officer

Officer
3,000 -2.0%
8.00
US$24,000 		3,000 -2.0% 8.00 US$24,000
2020-06-05 2020-06-04 PlS Planned sale
Kendall Keith J

CEO and President

Executive Director
50,000 -7.3%
5.11
US$255,310 		50,000 -7.3% 5.11 US$255,310
2020-05-11 2020-05-08 PlS Planned sale
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer

Officer
40,000 -4.2%
5.00
US$200,000 		40,000 -4.2% 5.00 US$200,000
2020-05-01 2020-04-29 PlS Planned sale
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer
40,000 -3.8%
4.50
US$180,000 		40,000 -3.8% 4.50 US$180,000
2020-05-04 2020-04-27 PlS Planned sale
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer
40,000 -4.1%
4.00
US$160,000 		40,000 -4.1% 4.00 US$160,000
2020-05-04 2020-04-14 PlS Planned sale
2.2
Schobel Alexander Mark

Chief Innovation/Tech Officer
40,000 -3.9%
3.70
US$148,000 		40,000 -3.9% 3.70 US$148,000
2020-03-18 2020-03-16 B Purchase
3.2
Boyd Peter E.

SVP-Bus. Process & Info. Tech.
2,000 +4.0%
1.50
US$3,000 		2,000 +4.0% 1.50 US$3,000
2020-03-18 2020-03-16 B Purchase
3.4
BRAENDER LORI J

SVP, General Counsel
14,000 +127.3%
1.54
US$21,624 		14,000 +127.3% 1.54 US$21,624
2019-08-27 2019-08-27 B Purchase Barber Daniel

SVP-Chief Operating Officer
2,000 +2.0%
3.99
US$7,980 		2,000 +2.0% 3.99 US$7,980
2019-08-22 2019-08-21 B Purchase Scibetta James S
900 +2.9%
3.81
US$3,429 		900 +2.9% 3.81 US$3,429
2019-08-22 2019-08-20 B Purchase Scibetta James S
11,310 +58.2%
3.80
US$43,001 		11,310 +58.2% 3.80 US$43,001
2019-08-22 2019-08-19 B Purchase Scibetta James S
10,761 +124.2%
3.77
US$40,547 		10,761 +124.2% 3.77 US$40,547
2019-08-20 2019-08-14 B Purchase Kendall Keith J

CEO and President
1,000 +0.2%
3.65
US$3,650 		1,000 +0.2% 3.65 US$3,650
2019-08-20 2019-08-14 B Purchase Kendall Keith J

CEO and President
1,000 +0.2%
3.70
US$3,697 		1,000 +0.2% 3.70 US$3,697
2019-08-20 2019-08-13 B Purchase Kendall Keith J

CEO and President
1,000 +0.2%
4.05
US$4,045 		1,000 +0.2% 4.05 US$4,045
2019-08-13 2019-08-12 B Purchase Boyd Peter E.

SVP-Bus. Process & Info. Tech.
600 +1.2%
3.81
US$2,286 		600 +1.2% 3.81 US$2,286
2019-08-20 2019-08-09 B Purchase Kendall Keith J

CEO and President
2,000 +0.3%
4.00
US$7,990 		2,000 +0.3% 4.00 US$7,990
2019-08-20 2019-08-09 B Purchase Kendall Keith J

CEO and President
1,000 +0.2%
3.93
US$3,925 		1,000 +0.2% 3.93 US$3,925
2019-08-20 2019-08-09 B Purchase Kendall Keith J

CEO and President
2,000 +0.3%
3.84
US$7,680 		2,000 +0.3% 3.84 US$7,680
2019-08-13 2019-08-09 B Purchase BRAENDER LORI J

SVP, General Counsel
10,000 +1000.0%
4.07
US$40,747 		10,000 +1000.0% 4.07 US$40,747
2019-08-13 2019-08-09 B Purchase Wood Theresa

SVP-HR and Org. Development
1,000 +1.3%
3.99
US$3,990 		1,000 +1.3% 3.99 US$3,990
2018-12-11 2018-12-10 B Purchase Schobel Alexander Mark

Chief Innovation/Tech Officer
1,000 +0.1%
7.78
US$7,780 		1,000 +0.1% 7.78 US$7,780
2018-12-10 2018-12-10 B Purchase Barber Daniel

SVP-Chief Strategy/Dev Officer
1,000 +1.0%
8.00
US$8,000 		1,000 +1.0% 8.00 US$8,000
2018-12-10 2018-12-06 B Purchase Schobel Alexander Mark

Chief Innovation/Tech Officer
2,000 +0.2%
8.69
US$17,380 		2,000 +0.2% 8.69 US$17,380
2018-12-07 2018-12-06 B Purchase Maxwell John T.

SVP-Chief Financial Officer
5,000 +3.4%
8.87
US$44,350 		5,000 +3.4% 8.87 US$44,350
2018-11-29 2018-11-27 B Purchase BRAENDER LORI J

General Counsel
1,000 +inf%
10.57
US$10,570 		1,000 +inf% 10.57 US$10,570
2018-11-28 2018-11-27 B Purchase Kendall Keith J

CEO and President
1,000 +0.2%
9.87
US$9,870 		1,000 +0.2% 9.87 US$9,870
2018-11-26 2018-11-26 B Purchase Wood Theresa

SVP-HR and Org. Development
500 +0.6%
10.34
US$5,170 		500 +0.6% 10.34 US$5,170
2018-11-26 2018-11-23 B Purchase Kendall Keith J

CEO and President
1,950 +0.3%
9.90
US$19,305 		1,950 +0.3% 9.90 US$19,305
2018-12-03 2018-11-21 B Purchase Marshall Ken W.

Commercial Leader
1,445 +inf%
10.15
US$14,667 		1,445 +inf% 10.15 US$14,667
2018-11-26 2018-11-21 B Purchase Kendall Keith J

CEO and President
6,000 +1.0%
10.17
US$61,020 		6,000 +1.0% 10.17 US$61,020
Explore more

More insider trading research around Aquestive Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America